ALBERT DAVID
|
The Current P/E Ratio of ALBERT DAVID is 21.63.
| Share Price | ₹856.3 | Sep 16,2026 |
| Market Cap | ₹488.1 Cr | |
| Earnings-TTM | ₹22.6 Cr | TTM-Standalone Results |
| Price/Earnings | 21.63x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of ALBERT DAVID
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹488.1 Cr] as on Sep 16,2026
(/) Earnings [ ₹22.6 Cr] based on TTM-Standalone Results
(=) P/E Ratio [ 21.63x ]
Thus, for ALBERT DAVID , the investors are currently willing to pay 21.63 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of ALBERT DAVID !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of ALBERT DAVID over the last five years.
Historical PE (Price/Earnings) ratio chart of ALBERT DAVID
PE Ratio Performance Analysis for ALBERT DAVID
- ALBERT DAVID 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 10.35x.
- ALBERT DAVID 's operated at median p/e ratio of 8.14x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, ALBERT DAVID 's p/e ratio peaked in Mar2025 at 26.92x.
- ALBERT DAVID 's p/e ratio hit its five-year low in Mar2026 of 0x.
How does ALBERT DAVID 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| ALBERT DAVID | 22.57 | 21.63 | 488.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 12,172.70 | 36.53 | 444,717.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 83.50 | 244,223.0 |
| TORRENT PHARMACEUTICALS LTD | 2,156.00 | 85.09 | 183,453.0 |
| CIPLA LTD | 3,364.84 | 32.65 | 109,849.0 |
| DR REDDYS LABORATORIES LTD | 3,169.30 | 30.16 | 95,591.8 |
| MANKIND PHARMA LTD | 2,055.11 | 45.18 | 92,852.5 |
| LUPIN LTD | 5,551.01 | 16.86 | 93,611.5 |
| ZYDUS LIFESCIENCES LTD | 4,492.20 | 24.54 | 110,224.0 |
| AUROBINDO PHARMA LTD | 3,712.74 | 25.43 | 94,419.5 |
| LAURUS LABS LTD | 1,090.76 | 94.41 | 102,984.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs ALBERT DAVID 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 16.86x |
| Max industry PE | 94.41x |
| Median industry PE | 32.65x |
| Average industry PE | 45.09x |
You may also like the below Video Courses